These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2067120)

  • 1. Treatment of metastatic renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
    Kotake T; Kinouchi T; Saiki S; Kuroda M; Miki T; Kiyohara H; Usami M
    Jpn J Clin Oncol; 1991 Feb; 21(1):46-51. PubMed ID: 2067120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon].
    Kawamura J; Yamauchi T; Hashimura T; Yoshida O; Kohnami T; Tomoyoshi T; Ogura K; Fukuyama T; Nakagawa K
    Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of advanced renal cell carcinoma with interferon alpha and OK-432 (streptococcal preparation)].
    Shinoda M; Naide Y
    Hinyokika Kiyo; 1992 Nov; 38(11):1299-304. PubMed ID: 1485585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
    Vugrin D; Hood L; Taylor W; Laszlo J
    Cancer Treat Rep; 1985; 69(7-8):817-20. PubMed ID: 4016792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
    Kinouchi T; Saiki S; Maeda O; Kuroda M; Usami M; Kotake T
    J Urol; 1997 May; 157(5):1604-7. PubMed ID: 9112486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of pulmonary metastasis from renal cell carcinoma in which complete remission was achieved by interferon therapy (r-IFN-alpha A, Ro 22-8181)].
    Ishito N; Wada F; Aramaki K; Asano S; Johsen T
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):380-3. PubMed ID: 3947113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of renal cell carcinoma. 3. Interferon therapy].
    Kobayashi M; Imai K; Kiren H; Nakai K; Saruki K; Umeyama T; Ito Y; Yamanaka H; Makino T; Machida M
    Hinyokika Kiyo; 1987 Apr; 33(4):508-14. PubMed ID: 3618421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials.
    Ryan CW; Vogelzang NJ; Dumas MC; Kuzel T; Stadler WM
    Cancer; 2000 Mar; 88(6):1317-24. PubMed ID: 10717612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of complete resolution of multiple metastases of advanced renal cell carcinoma following partial jejunotomy in intestinal metastases and interferon therapy].
    Miyata M; Watabe Y; Okamura K; Fujisawa M; Arima S; Yachiku S
    Hinyokika Kiyo; 1988 Oct; 34(10):1783-8. PubMed ID: 3245527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report].
    Kanno H; Kitami K; Senga Y; Takahashi T; Nagashima Y
    Hinyokika Kiyo; 1993 Aug; 39(8):725-9. PubMed ID: 8379474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does vinblastine add to the potency of alpha interferon in the treatment of renal cell carcinoma?
    Merimsky O; Shnider BI; Chaitchik S
    Mol Biother; 1991 Mar; 3(1):34-7. PubMed ID: 2069758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individualized therapy with alpha-interferon in metastatic renal cell carcinoma].
    Gross AJ; Dieckmann KP; Krain J; Huland H
    Urologe A; 1995 Mar; 34(2):158-61. PubMed ID: 7754588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
    Kinouchi T; Meguro N; Maeda O; Saiki S; Kuroda M; Usami M; Kotake T
    Int J Urol; 1996 Jan; 3(1 Suppl):S41-3. PubMed ID: 24304021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.
    Clark PE; Hall MC; Miller A; Ridenhour KP; Stindt D; Lovato JF; Patton SE; Brinkley W; Das S; Torti FM
    Urology; 2004 Jun; 63(6):1061-5. PubMed ID: 15183950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination therapy with interferon-alpha and continuous infusion of 5-fluorouracil for advanced renal cell carcinoma].
    Noguchi S; Shuin T; Kubota Y; Masuda M; Yao M; Hosaka M
    Hinyokika Kiyo; 1995 Jul; 41(7):517-20. PubMed ID: 7668181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interleukin 2 based ambulatory therapy of metastatic renal cell carcinoma].
    Atzpodien J; Kirchner H; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():38-43. PubMed ID: 8692118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
    Kirkwood JM; Harris JE; Vera R; Sandler S; Fischer DS; Khandekar J; Ernstoff MS; Gordon L; Lutes R; Bonomi P
    Cancer Res; 1985 Feb; 45(2):863-71. PubMed ID: 3881175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
    Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
    Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors].
    Niijima T; Akaza H; Koyanagi T; Togashi M; Kumamoto Y; Funyu T; Suzuki T; Orikasa S; Yoshikawa K; Koiso K
    Hinyokika Kiyo; 1992 Oct; 38(10):1201-7. PubMed ID: 1481783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.